New York State Common Retirement Fund Ultragenyx Pharmaceutical Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 63,571 shares of RARE stock, worth $2.78 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,571
Previous 54,724
16.17%
Holding current value
$2.78 Million
Previous $2.25 Million
57.0%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$435 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$245 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$224 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$182 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$134 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.06B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...